Randomized study to characterize glycemic control and short-term pulmonary function in patients with type 1 diabetes receiving inhaled human insulin (Exubera)

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 6, 2007, Pages 2211-2214

  Norwood, Paul ^a   Dumas, Richard ^b   Cefalu, William ^c   Yale, Jean Francois ^d   England, Richard ^e   Riese, Richard ^e   Teeter, John ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Laval Clinical Research Center   (Canada)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; GLYCOSYLATED HEMOGLOBIN; INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DRUG DOSAGE FORM COMPARISON; DRUG WITHDRAWAL; FORCED EXPIRATORY VOLUME; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY;

EID: 34347219459     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0631     Document Type: Article

References (10)

1. The Diabetes Control and Complications Trial Research (DCCT) Group 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
2. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complication Research Group 2002 Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287:2563-2569
3. Korytkowski M 2002 When oral agents fail: practical barriers to starting insulin. Int J Obes Relat Metab Disord 26(Suppl 3):S18-S24
4. Zambanini A, Newson RB, Maisey M, Feher MD 1999 Injection related anxiety in insulin-treated diabetes. Diabetes Res Clin Pract 46:239-246
5. Hermansen K 2004 Waiting to inhale: noninjectable insulin, are we there yet? Curr Diab Rep 4:335-341
6. Hollander PA, Blonde L, Rowe R, Mehta AE, Milburn JL, Hershon KS, Chiasson JL, Levin SR 2004 Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial. Diabetes Care 27:2356-2362
7. Quattrin T, Belanger A, Bohannon NJ, Schwartz SL 2004 Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial. Diabetes Care 27:2622-2627
8. Skyler JS, Weinstock RS, Raskin P, Yale Y-F, Barrett E, Gerich JE, Gerstein HC, for the Inhaled Insulin Phase III Type 1 Diabetes Study Group 2005 Use of inhaled insulin in a basal/bolus insulin regimen in subjects with type 1 diabetes: a 6-month, randomized, comparative trial. Diabetes Care 28:1630-1635
9. Teeter JG, Riese RJ 2006 Dissociation of lung function changes with humoral immunity during inhaled human insulin therapy. Am J Respir Crit Care Med 173:1194-1200
10. co) in a multicenter clinical trial. Proc Am Thorac Soc 2:A34